Breaking News Instant updates and real-time market news.

EVH

Evolent Health

$17.48

0.275 (1.60%)

14:25
08/23/17
08/23
14:25
08/23/17
14:25

Evolent Health participates in a conference call with William Blair

Healthcare Technology Analyst Ryan Daniels hosts a conference call with CEO Williams and CFO McGrane on August 23 at 3 pm hosted by William Blair.

  • 23

    Aug

  • 06

    Sep

EVH Evolent Health
$17.48

0.275 (1.60%)

08/18/17
LEER
08/18/17
NO CHANGE
Target $32
LEER
Outperform
Leerink views CMS proposal as only modest negative for Evolent
Leerink analyst David Larsen says shares of Evolent Health traded lower this week after the Centers for Medicare & Medicaid Service announced a proposed rule that scales back the Comprehensive Care for Joint Replacement model and cancels the mandatory Episode Payment Models and Cardiac Rehabilitation Incentive payment model which were slated to begin in January 2018. The move by CMS is a "modest negative" for Evolent because cardiac care and joint replacements tend to be high revenue and earnings drivers for hospitals, Larsen tells investors in a research note. The analyst, however, remains positive on the shares. He believes that with or without these two programs, the industry-wide shift towards value-based care will continue. Larsen keeps an Outperform rating on Evolent with a $32 price target.
08/18/17
JPMS
08/18/17
NO CHANGE
JPMS
Overweight
Evolent Health 29% selloff this week overdone, says JPMorgan
JPMorgan analyst Stephanie Davis views the 29% selloff this week in shares of Evolent Health following the company's Q2 results as overdone. The analyst says the pullback is a buying opportunity. Davis, while acknowledging that FY18 is a larger contract renewal year for Evolent, notes the Q2 results did not change her long term thesis. The analyst continues to believe in the company's "superior positioning to win in the shift to value based care." She keeps an Overweight rating on Evolent Health.
08/08/17
BARD
08/08/17
NO CHANGE
Target $35
BARD
Outperform
Evolent Health shares inexpensive relative to growth, says Baird
Baird analyst Matthew Gillmor noted Evolent Health reported better than expected Q2 results and raised guidance. He said the pipeline is deep with large opportunities, yet he believes investors may be confused with regards to 2018 visibility. The analyst said shares are simply too inexpensive relative to the company's organic growth rate and he expects its valuation will reset higher at some point. Gillmor reiterated his Outperform rating and $35 price target on Evolent Health shares.
08/08/17
ADAM
08/08/17
NO CHANGE
Target $32
ADAM
Buy
Evolent Health long-term thesis intact, says Canaccord
Canaccord analyst Richard Close believes Evolent Health shares will likely pullback on the company's secondary offering and guidance, with which the company raised its revenue view but lowered the top end of its EBITDA outlook. The company remained bullish on its pipeline, but there seemed to be a change in tone regarding commentary surrounding the need for clarity from HHS and CMS on the shift to value based care, Close tells investors. He said his long-term thesis remains intact and he reiterated his Buy rating and $32 price target on Evolent Health shares.

TODAY'S FREE FLY STORIES

RMP

Rice Midstream

$20.33

-0.56 (-2.68%)

03:47
02/22/18
02/22
03:47
02/22/18
03:47
Downgrade
Rice Midstream rating change  »

Rice Midstream downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASND

Ascendis Pharma

$58.00

-1 (-1.69%)

03:44
02/22/18
02/22
03:44
02/22/18
03:44
Syndicate
Ascendis Pharma 3.947M share Secondary priced at $57.00 »

JPMorgan, BofA/Merrill…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

EVTC

Evertec

$16.05

-0.15 (-0.93%)

03:42
02/22/18
02/22
03:42
02/22/18
03:42
Upgrade
Evertec rating change  »

Evertec upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WRI

Weingarten Realty

$27.15

-0.55 (-1.99%)

03:37
02/22/18
02/22
03:37
02/22/18
03:37
Downgrade
Weingarten Realty rating change  »

Weingarten Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

MNTA

Momenta

$16.35

0.4 (2.51%)

03:36
02/22/18
02/22
03:36
02/22/18
03:36
Upgrade
Momenta rating change  »

Momenta upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOC

Holly

03:35
02/22/18
02/22
03:35
02/22/18
03:35
Upgrade
Holly rating change  »

Holly upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLVS

Clovis

$54.93

1.22 (2.27%)

03:34
02/22/18
02/22
03:34
02/22/18
03:34
Upgrade
Clovis rating change  »

Clovis upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

HST

Host Hotels

$19.22

-0.29 (-1.49%)

03:34
02/22/18
02/22
03:34
02/22/18
03:34
Upgrade
Host Hotels rating change  »

Host Hotels upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

SLCA

U.S. Silica

$25.15

-5.6 (-18.21%)

03:33
02/22/18
02/22
03:33
02/22/18
03:33
Downgrade
U.S. Silica rating change  »

U.S. Silica downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

JELD

Jeld-Wen

$34.50

-3.14 (-8.34%)

03:33
02/22/18
02/22
03:33
02/22/18
03:33
Downgrade
Jeld-Wen rating change  »

Jeld-Wen downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 28

    Mar

TEO

Telecom Argentina

$34.09

-0.19 (-0.55%)

03:32
02/22/18
02/22
03:32
02/22/18
03:32
Downgrade
Telecom Argentina rating change  »

Telecom Argentina…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

03:30
02/22/18
02/22
03:30
02/22/18
03:30
General news
FX Action: USD-CAD clocked a two-month high »

FX Action: USD-CAD…

JELD

Jeld-Wen

$34.50

-3.14 (-8.34%)

03:27
02/22/18
02/22
03:27
02/22/18
03:27
Downgrade
Jeld-Wen rating change  »

Jeld-Wen downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 28

    Mar

ALKS

Alkermes

$63.19

-1.56 (-2.41%)

03:27
02/22/18
02/22
03:27
02/22/18
03:27
Downgrade
Alkermes rating change  »

Alkermes downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSA

MSA Safety

$80.25

3.79 (4.96%)

03:25
02/22/18
02/22
03:25
02/22/18
03:25
Upgrade
MSA Safety rating change  »

MSA Safety upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Mar

02:50
02/22/18
02/22
02:50
02/22/18
02:50
General news
FX Update: The dollar has continued to mostly trade firmer »

FX Update: The dollar…

02:15
02/22/18
02/22
02:15
02/22/18
02:15
General news
Asian Market Summary: »

Asian Market Summary:…

00:00
02/22/18
02/22
00:00
02/22/18
00:00
General news
Breaking General news story  »

Federal Reserve Vice…

NEM

Newmont Mining

$38.16

-0.23 (-0.60%)

, HRL

Hormel Foods

$32.68

-1.12 (-3.31%)

20:25
02/21/18
02/21
20:25
02/21/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

NEM

Newmont Mining

$38.16

-0.23 (-0.60%)

HRL

Hormel Foods

$32.68

-1.12 (-3.31%)

APA

Apache

$37.20

-1.1 (-2.87%)

LDOS

Leidos

$65.21

-1.02 (-1.54%)

W

Wayfair

$95.69

-0.61 (-0.63%)

OA

Orbital ATK

$131.80

-0.02 (-0.02%)

TREE

LendingTree

$371.25

-7.8 (-2.06%)

SFM

Sprouts Farmers Market

$26.12

0.12 (0.46%)

TPX

Tempur Sealy

$54.97

1.17 (2.17%)

SAFM

Sanderson Farms

$128.00

-3.44 (-2.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 25

    Feb

  • 28

    Feb

  • 07

    Mar

  • 08

    Mar

  • 20

    Mar

  • 29

    Mar

AIMT

Aimmune

$32.21

-2.75 (-7.87%)

20:04
02/21/18
02/21
20:04
02/21/18
20:04
Syndicate
Aimmune 5.5M share Secondary priced at $32.00 »

BofA/Merrill, Cantor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

  • 11

    Mar

  • 22

    Feb

20:00
02/21/18
02/21
20:00
02/21/18
20:00
General news
Breaking General news story  »

Minneapolis Federal…

NUAN

Nuance

$16.28

-0.28 (-1.69%)

19:10
02/21/18
02/21
19:10
02/21/18
19:10
Periodicals
Nuance discontinues Swype feature development, Verge reports »

Nuance has ceased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

SSNLF

Samsung

, QCOM

Qualcomm

$63.40

-0.59 (-0.92%)

19:04
02/21/18
02/21
19:04
02/21/18
19:04
Hot Stocks
Samsung, Qualcomm expand foundry cooperation on EUV process technology »

Samsung Electronics…

SSNLF

Samsung

QCOM

Qualcomm

$63.40

-0.59 (-0.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 06

    Mar

CATY

Cathay General

$42.84

0.43 (1.01%)

18:59
02/21/18
02/21
18:59
02/21/18
18:59
Hot Stocks
Cathay General executive chairman Cheng sells 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SUN

Sunoco

$30.00

-0.08 (-0.27%)

18:42
02/21/18
02/21
18:42
02/21/18
18:42
Earnings
Sunoco reports Q4 EPS $2.01, may not compare to consensus 35c »

Reports Q4 revenue $3B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.